Company intelligence / Profile preview

Beijing Handian Pharmaceutical

Beijing, Beijing Shi / Beijing Municipality, Chinanewsfilecorp.com ↗

Ownership: Private
Development stage: Commercial

Overview

Beijing Handian Pharmaceutical is a private Chinese pharmaceutical company specializing in the development and production of traditional Chinese medicines, with a focus on herbal formulations for nervous system diseases. Its lead product, Ziyedan Capsule, is approved in China for the treatment of flank pain. The company has been active since 2005 and operates as a national high-tech enterprise integrating production, education, and research.[1][3][4] No clinical trial results or broader pipeline data are publicly available.

Therapeutic areas: NeurologyNephrology
Modalities: Herbal medicineSmall molecule
Industry: Biotech

Drug pipeline

2 assets

Rongjin Juanbi

Unknown

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Beijing Handian Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Handian Pharmaceutical.

Explore the full profile